Biosyent (TSXV:RX) Cyclically Adjusted Book per Share: C$2.62 (As of Mar. 2026)


TSXV:RX Biosyent Inc TSXV:RX
100 GF Score
Price C$14.64
GF Value C$16.43
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Biosyent Cyclically Adjusted Book per Share?

Biosyent TSXV:RX +1.53% 100 Cyclically Adjusted Book per Share is C$2.62 as of Mar. 2026. GuruFocus rates TSXV:RX with a GF Score™ of 100/100 and a GF Value™ of C$16.43 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Biosyent's adjusted book value per share for the three months ended in Mar. 2026 was C$3.935. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$2.62 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biosyent's average Cyclically Adjusted Book Growth Rate was 13.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 19.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 27.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Biosyent was 47.40% per year. The lowest was -4.40% per year. And the median was 26.40% per year.

As of today (2026-07-09), Biosyent's current stock price is C$14.64. Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was C$2.62. Biosyent's Cyclically Adjusted PB Ratio of today is 5.59.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biosyent was 32.81. The lowest was 4.16. And the median was 6.42.


Biosyent  (TSXV:RX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biosyent's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=14.64/2.62
=5.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Biosyent was 32.81. The lowest was 4.16. And the median was 6.42.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Biosyent Cyclically Adjusted Book per Share Related Terms


Biosyent Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Biosyent's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyent Cyclically Adjusted Book per Share Chart

Biosyent Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.64 1.94 2.22 2.52

Biosyent Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 2.39 2.46 2.52 2.62

TSXV:RX vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyent Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biosyent's Cyclically Adjusted PB Ratio falls into.


TSXV:RX
100GF Score
Biosyent Inc TSXV:RX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosyent Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biosyent's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.935/132.2623*132.2623
=3.935

Current CPI (Mar. 2026) = 132.2623.

Biosyent Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.012 102.002 1.312
201609 1.104 101.765 1.435
201612 1.162 101.449 1.515
201703 1.224 102.634 1.577
201706 1.337 103.029 1.716
201709 1.431 103.345 1.831
201712 1.531 103.345 1.959
201803 1.615 105.004 2.034
201806 1.734 105.557 2.173
201809 1.829 105.636 2.290
201812 1.912 105.399 2.399
201903 1.896 106.979 2.344
201906 1.795 107.690 2.205
201909 1.860 107.611 2.286
201912 1.907 107.769 2.340
202003 1.952 107.927 2.392
202006 1.959 108.401 2.390
202009 2.039 108.164 2.493
202012 2.093 108.559 2.550
202103 2.184 110.298 2.619
202106 2.268 111.720 2.685
202109 2.359 112.905 2.763
202112 2.513 113.774 2.921
202203 2.581 117.646 2.902
202206 2.654 120.806 2.906
202209 2.713 120.648 2.974
202212 2.758 120.964 3.016
202303 2.763 122.702 2.978
202306 2.779 124.203 2.959
202309 2.923 125.230 3.087
202312 2.961 125.072 3.131
202403 2.975 126.258 3.116
202406 3.057 127.522 3.171
202409 3.221 127.285 3.347
202412 3.103 127.364 3.222
202503 3.200 129.181 3.276
202506 3.340 129.892 3.401
202509 3.543 130.287 3.597
202512 3.682 130.366 3.736
202603 3.935 132.262 3.935

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of C$2.62 mean?
Biosyent (TSXV:RX) has a Cyclically Adjusted Book per Share of C$2.62 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biosyent and its competitors.
Is Biosyent's Cyclically Adjusted Book per Share too high?
Biosyent's current Cyclically Adjusted Book per Share is C$2.62. Overall, Biosyent has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biosyent's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Biosyent's Cyclically Adjusted Book per Share of C$2.62 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Biosyent and its competitors. Biosyent's current Cyclically Adjusted Book per Share is C$2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosyent stock overvalued right now?
Based on GuruFocus' analysis, Biosyent (TSXV:RX) is currently considered Modestly Undervalued. The stock's GF Value™ is C$16.43, compared to a current price of C$14.64 — trading 10.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is C$2.62. Biosyent's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Biosyent (TSXV:RX), the current Cyclically Adjusted Book per Share is C$2.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biosyent (TSXV:RX) Overvalued in 2026?

Based on GuruFocus' analysis, Biosyent stock appears to be undervalued. The current stock price of C$14.64 is trading 10.9% below its estimated GF Value™ of C$16.43. GuruFocus considers Biosyent to be Modestly Undervalued.

Key valuation signals for TSXV:RX:

  • Cyclically Adjusted Book per Share: C$2.62
  • GF Value™: C$16.43 vs. price of C$14.64 (10.9% below fair value)
  • GF Score™: 100/100 with 4 warning signs

No single metric tells the full story. See the TSXV:RX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biosyent Business Description

Other Exchanges BIOYF:USA
Address 2476 Argentia Road, Suite 402, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It markets and delivers a diverse range of healthcare products, including over-the-counter, behind-the-counter, and prescription options. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX Pd, Inofolic, Gelclair, Cathejell, RepaGyn, Proktis-M, and Tibella. The company derives revenue from pharmaceutical and insecticide business. Geographically, it derives maximum revenue from Canada and also has its presence internationally.
100GF Score

Get the complete analysis for TSXV:RX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$14.64
Price
C$16.43
GF Value